TY - JOUR
T1 - Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents
AU - the DAN05 Consortium
AU - Hood, Korey K.
AU - Garcia-Willingham, Natasha
AU - Hanes, Sarah
AU - Tanenbaum, Molly L.
AU - Ware, Julia
AU - Boughton, Charlotte K.
AU - Allen, Janet M.
AU - Wilinska, Malgorzata E.
AU - Tauschmann, Martin
AU - Denvir, Louise
AU - Thankamony, Ajay
AU - Campbell, Fiona
AU - Wadwa, R. Paul
AU - Buckingham, Bruce A.
AU - Davis, Nikki
AU - DiMeglio, Linda A.
AU - Mauras, Nelly
AU - Besser, Rachel E.J.
AU - Ghatak, Atrayee
AU - Weinzimer, Stuart A.
AU - Fox, D. Steven
AU - Kanapka, Lauren
AU - Kollman, Craig
AU - Sibayan, Judy
AU - Beck, Roy W.
AU - Hovorka, Roman
N1 - Publisher Copyright:
© 2022 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
PY - 2022/12
Y1 - 2022/12
N2 - Aim: To examine changes in the lived experience of type 1 diabetes after use of hybrid closed loop (CL), including the CamAPS FX CL system. Materials and Methods: The primary study was conducted as an open-label, single-period, randomized, parallel design contrasting CL versus insulin pump (with or without continuous glucose monitoring). Participants were asked to complete patient-reported outcomes before starting CL and 3 and 6 months later. Surveys assessed diabetes distress, hypoglycaemia concerns and quality of life. Qualitative focus group data were collected at the completion of the study. Results: In this sample of 98 youth (age range 6-18, mean age 12.7 ± 2.8 years) and their parents, CL use was not associated with psychosocial benefits overall. However, the subgroup (n = 12) using the CamAPS FX system showed modest improvements in quality of life and parent distress, reinforced by both survey (p <.05) and focus group responses. There were no negative effects of CL use reported by study participants. Conclusions: Closed loop use via the CamAPS FX system was associated with modest improvements in aspects of the lived experience of managing type 1 diabetes in youth and their families. Further refinements of the system may optimize the user experience.
AB - Aim: To examine changes in the lived experience of type 1 diabetes after use of hybrid closed loop (CL), including the CamAPS FX CL system. Materials and Methods: The primary study was conducted as an open-label, single-period, randomized, parallel design contrasting CL versus insulin pump (with or without continuous glucose monitoring). Participants were asked to complete patient-reported outcomes before starting CL and 3 and 6 months later. Surveys assessed diabetes distress, hypoglycaemia concerns and quality of life. Qualitative focus group data were collected at the completion of the study. Results: In this sample of 98 youth (age range 6-18, mean age 12.7 ± 2.8 years) and their parents, CL use was not associated with psychosocial benefits overall. However, the subgroup (n = 12) using the CamAPS FX system showed modest improvements in quality of life and parent distress, reinforced by both survey (p <.05) and focus group responses. There were no negative effects of CL use reported by study participants. Conclusions: Closed loop use via the CamAPS FX system was associated with modest improvements in aspects of the lived experience of managing type 1 diabetes in youth and their families. Further refinements of the system may optimize the user experience.
UR - https://www.scopus.com/pages/publications/85135595934
U2 - 10.1111/dom.14815
DO - 10.1111/dom.14815
M3 - Article
C2 - 35837984
AN - SCOPUS:85135595934
SN - 1462-8902
VL - 24
SP - 2309
EP - 2318
JO - Diabetes, Obesity and Metabolism
JF - Diabetes, Obesity and Metabolism
IS - 12
ER -